Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H30N2O4 |
Molecular Weight | 398.4953 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C4C(C[C@H]5N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OCCN6CCOCC6
InChI
InChIKey=GPFAJKDEDBRFOS-FKQDBXSBSA-N
InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/3283158Curator's Comment: Description was created based on several sources, including http://www.phadia.com/Global/ImmunoCAP%20Allergens/Product%20Leaflets/Product_Leaflet_c261_Pholcodine.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23773349
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3283158
Curator's Comment: Description was created based on several sources, including http://www.phadia.com/Global/ImmunoCAP%20Allergens/Product%20Leaflets/Product_Leaflet_c261_Pholcodine.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23773349
Pholcodine is an opioid that has been widely used worldwide since 1950 for the treatment of non-productive cough in children and adults. Illicit drug.
Additionally Pholcodine is a marker for sensitization to neuromuscular blocking agents (NMBA) and is intended for use as a diagnostic tool in NMBA-induced anaphylaxis.
CNS Activity
Originator
Sources: Chabrier, P., Guidicelli, R. & Thuillier, J. (1950) Etude chimique, pharmacologique et clinique d’un nouveau skdatif de la toux: la morpholyethyimorphine (M.E.M.). Annales Pharmaceutiques Francais. 8, 26 1-273.
Curator's Comment: Reference was retrieved from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.1988.tb00502.x/epdf
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P33535|||Q64064 Gene ID: 25601.0 Gene Symbol: Oprm1 Target Organism: Rattus norvegicus (Rat) Sources: http://www.ncbi.nlm.nih.gov/pubmed/1851921 |
|||
Target ID: P35372|||G8XRH8|||Q5TDA1|||Q9UN57 Gene ID: 4988.0 Gene Symbol: OPRM1 Target Organism: Homo sapiens (Human) Sources: http://www.ebi.ac.uk/chebi/searchId.do?chebiId=53579 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Pholcodine Linctus B.P. Approved UseCough |
|||
Diagnostic | ImmunoCAP® Allergen c261 Approved UseAnaphylaxis to neuromuscular blocking agents |
PubMed
Title | Date | PubMed |
---|---|---|
Angle closure risk from proprietary medicines. | 2001 Apr |
|
Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. | 2001 Jul |
|
The toxicity of opiates and their metabolites in HepG2 cells. | 2003 Oct 25 |
|
Allergy to pholcodine: first case documented by oral challenge. | 2005 Apr |
|
Automated multiple development thin-layer chromatography for separation of opiate alkaloids and derivatives. | 2005 Jul 8 |
|
Comparative efficacy and tolerability of pholcodine and dextromethorphan in the management of patients with acute, non-productive cough : a randomized, double-blind, multicenter study. | 2006 |
|
Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study. | 2006 Jan |
|
Site-specific acid-base properties of pholcodine and related compounds. | 2006 Nov |
|
Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. | 2007 Aug |
|
Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. | 2007 Dec |
|
IgE-mediated anaphylactic reactions to neuromuscular blocking agents: can they be prevented? | 2008 Sep |
|
The pholcodine story. | 2009 Aug |
|
Suspected anaphylactic reactions associated with anaesthesia. | 2009 Feb |
|
[Anaphylaxis during anaesthesia]. | 2010 Mar 11 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
||
|
DEA NO. |
9314
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
||
|
WHO-ATC |
R05DA08
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
||
|
WHO-VATC |
QR05DA08
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
272
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
509-67-1
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
C008872
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
LPP64AWZ7L
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
DTXSID70198923
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
DB09209
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
53579
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
M8711
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | Merck Index | ||
|
CHEMBL2105224
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
C87365
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
PHOLCODINE
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
SUB09795MIG
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
208-102-9
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
5311356
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | |||
|
33431
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY | RxNorm | ||
|
2154
Created by
admin on Fri Dec 16 16:58:00 UTC 2022 , Edited by admin on Fri Dec 16 16:58:00 UTC 2022
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)